RESUMO
Butaphosphan is an organic phosphorus compound used in several species for the prevention of rapid catabolic states, however, the mechanism of action remains unclear. This study aimed at determining the effects of butaphosphan on energy metabolism of mice receiving a normal or hypercaloric diet (HCD) and submitted or not to food restriction. Two experiments were conducted: (1) during nine weeks, animals were fed with HCD (n = 28) ad libitum, and at the 10th week, were submitted to food restriction and received butaphosphan (n = 14) or saline injections (n = 14) (twice a day, for seven days) and; (2) during nine weeks, animals were fed with a control diet (n = 14) or HCD (n = 14) ad libitum, and at the 10th week, all animals were submitted to food restriction and received butaphosphan or saline injections (twice a day, for seven days). In food restriction, butaphosphan preserved epididymal white adipose tissue (WAT) mass, increased glucose, NEFA, and the HOMA index. In mice fed HCD and submitted to food restriction, the butaphosphan preserved epididymal WAT mass. Control diet influences on PI3K, GCK, and Irs1 mRNA expression. In conclusion, butaphosphan increased blood glucose and reduced fat mobilization in overweight mice submitted to caloric restriction, and these effects are influenced by diet.
Assuntos
Glicemia/efeitos dos fármacos , Butilaminas/farmacologia , Dieta , Metabolismo Energético/efeitos dos fármacos , Insulina/metabolismo , Ácidos Fosfínicos/farmacologia , Transdução de Sinais/efeitos dos fármacos , Tecido Adiposo Branco/efeitos dos fármacos , Tecido Adiposo Branco/metabolismo , Animais , Glicemia/genética , Glicemia/metabolismo , Restrição Calórica , Ingestão de Energia , Ácidos Graxos não Esterificados/sangue , Expressão Gênica , Resistência à Insulina , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Sobrepeso/metabolismoRESUMO
The aim of this study was to determine the effect of growth hormone receptor (GHR) AluI, insulin-like growth factor type 1 (IGF-I) SnaBI, and signal transducer and activator 5A (STAT5A) BstEII polymorphisms in the reproductive performance of Holstein dairy cows and the frequency of this genotypes in cows managed in different systems. This work studied 381 and 506 Holstein cows from semiextensive and intensive systems, respectively. The frequency of genotypes GHRAluI (+/-), IGF-ISnaBI (-/-) and (+/-), and STAT5ABstEII (-/-) was higher in animals from semiextensive system, whereas the frequency of the genotypes GHRAluI (+/+) and IGF-ISnaBI (+/+) was higher in animals from intensive system (P < 0.05). In the intensive system, cows from the STAT5ABstEII (-/-) genotype had a longer calving-first heat interval (P = 0.03). In conclusion, there was no association between the genotypes of GHRAluI and IGF-ISnaBI and fertility of Holstein cows raised in semiextensive or intensive regimes, although the genotype frequencies of the evaluated polymorphisms were different between the studied systems. The STAT5ABstEII polymorphism was associated with calving-first heat interval in Holstein cows raised in the intensive system, indicating that this gene could be a molecular marker for genetic selection to improve reproductive performance.
Assuntos
Bovinos/genética , Fertilidade/genética , Fator de Crescimento Insulin-Like I/metabolismo , Polimorfismo Genético , Receptores da Somatotropina/metabolismo , Fator de Transcrição STAT5/metabolismo , Animais , Bovinos/fisiologia , Regulação da Expressão Gênica/fisiologia , Genótipo , Fator de Crescimento Insulin-Like I/genética , Receptores da Somatotropina/genética , Fator de Transcrição STAT5/genéticaRESUMO
O objetivo deste estudo foi determinar variações em parâmetros metabólicos e endócrinos de suínos machos durante o primeiro ano de vida e sua relação com a puberdade. Foram utilizados seis suínos acompanhados, de 22 a 360 dias deidade, com pesagens corporais e coletas de sangue a cada sete dias para avaliação dos níveis séricos de glicose, insulina, colesterol, albumina, ureia, cálcio, fósforo, aspartato aminotransferase (AST), gama glutariltransferase (GGT), ácidos graxos não esterificados (NEFA) e testosterona. A partir do ganho de peso e níveis de testosterona foram estabelecidos três períodos: pré-puberdade (1-5 meses de idade); puberdade (6-9 meses de idade); pós-puberdade (10-12 meses de idade), em que os níveis de testosterona foram de 0,6 ± 0,1 ng/mL, 1,8 ± 0,2 ng/mL e 1,8 ± 0,2 ng/mL, respectivamen- te (P < 0,0001). Foi observada correlação positiva entre a testosterona e níveis de albumina, idade e peso corporal, e correlação negativa entre testosterona e os níveis de cálcio, GGT e glicose. Os níveis de glicose diminuíram ao longo do desenvolvimento (P < 0,0001), e os níveis de NEFA foram maiores em pré-púberes (P = 0,01). A enzima GGT teve diminuição dos seus níveis a partir da puberdade (P < 0,0001), e a AST teve seus menores níveis na puberdade (P = 0,0003). A albumina apresentou maiores níveis durante a puberdade (P < 0,0001) e a ureia no período pós-puberdade (P < 0,0001). Os níveis de cálcio e fósforo apresentaram menores níveis no período pós-puberdade (P<0,0001). Assim, a puberdade representa um período de flutuação nos níveis de marcadores metabólicos de suínos machos híbridos, devido ao efeito da testosterona sobre o metabolismo energético, proteico e mineral.
The present study aimed to determine changes in endocrine and metabolic parameters in male pigs during the first year of life and its relation with the puberty. Six male pigs of 22 at 360 days of age were used in this study. Body weights and blood collection were performed every seven days for evaluation of serum glucose, insulin, cholesterol, albumin, urea,calcium, phosphorus, aspartate aminotransferase (AST), gamma glutamyltransferase (GGT), non-esterified fatty acids (NEFA) and testosterone. From the weight gain and testosterone levels were established three periods: prior to puberty (1-5 months old); puberty (6-9 months old); postpubertal (10-12 months old). During these periods testosterone levels were 0.6 ± 0.1 ng/mL, 1.8 ± 0.2 ng/mL and 1.8 ± 0.2 ng/mL, respectively (P < 0.0001). Positive correlation was observed between testosterone levels and albumin levels, age and body weight, and a negative correlation between testosterone levels and calcium, glucose and GGT. Glucose levels decreased throughout development (P < 0.0001) whereas NEFA levels were higher in pre-pubertal (P = 0.01). The enzyme GGT levels had decreased from puberty (P < 0.0001), and AST had their lowest levels at puberty (P = 0.0003). Albumin showed higher levels during puberty (P < 0.0001). The urea values were stable until puberty, and increased post-puberty (P < 0.0001). The levels of calcium and phosphorus levels had lower post-puberty (P < 0.0001). Thus, puberty is a period of fluctuation in the levels of metabolic markers of hybrid male pigs due to the effect of testosterone on energy, protein and mineral metabolism.
Assuntos
Animais , Albuminas/química , Puberdade/metabolismo , Testosterona/análise , Endocrinologia/métodos , Suínos/classificaçãoRESUMO
O objetivo deste estudo foi determinar o efeito do adsorvente (ADS) glucomanano modificado sobre parâmetros clínicos, hematológicos e ruminais de ovinos submetidos a dietas contendo aflatoxina (AFLA). Foram utilizadas 22 ovelhas mestiças (Corriedale e Texel), com 18 meses de idade. Os animais foram divididos em quatro grupos, de acordo com a adição de AFLA (1,5 PPM) ou ADS (2 PPM) na fração concentrada da dieta: animais recebendo AFLA na dieta (AFLA; n=6); animais recebendo AFLA e ADS na dieta (AFLA/ADS; n=6); animais recebendo ADS na dieta (ADS; n=5) e grupo controle, sem adição de ADS ou AFLA na dieta (CONTROLE; n=5). As dietas foram fornecidas por um período de 42 dias. Foram realizadas coletas de fluido ruminal a cada sete dias e avaliações clínicas (exame físico geral, urinálise e hemograma) a cada 10 dias. Quanto ao perfil leucocitário, a suplementação com adsorvente aumentou a concentração plasmática de eosinófilos. Os demais parâmetros clínicos e ruminais não foram influenciados pela presença do adsorvente ou da aflatoxina na dieta. Assim, o adsorvente glucomanano modificado influenciou a resposta leucocitária de ovinos, porém sem efeito na função ruminal e nos parâmetros clínicos avaliados.
The aim of this study was to determine the effect of modified glucomannan adsorbent (ADS) on the clinical, hematological and ruminal parameters in sheep subjected to diets containing aflatoxins (AFLA). Twenty two crossbred ewes (Corriedale vs Texel), aging 18 months were separated into four groups according to the addition of AFLA (1,5 PPM) or ADS (2 PPM) in the concentrate portion of the diet: animals receiving AFLA in the diet (AFLA; n=6); animals receiving AFLA and ADS in the diet (AFLA/ADS; n=6); animals receiving ADS in the diet (n=5) and control group, without addition of the ADS or AFLA in the diet (CONTROL; n=5). The diets were supplied during 42 days. Ruminal fluid was collected and analysed every seven days and the clinical evaluations (clinical examination, urinalysis, and hemogram) every 10 days. The addition of adsorbent increased the plasmatic concentration of eosinophiles. Clinical and ruminal parameters were not affected by the presence of adsorbent or aflatoxin into the diet. The modified glucomannan adsorbent influenced the leukocyte response of sheep, but no effect on ruminal function and clinical parameters.
